Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 308 entries
View as:

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00410761 Org: User:
Start: 11/30/06 End: 07/26/24 Due: 07/26/25

A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)

Phase: N/A Priority: Normal
NCT ID: NCT00317642 Org: User:
Start: 08/31/06 End: 01/31/12 Due: 01/31/13

SR-45023A in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003822 Org: User:
Start: 08/31/98 End: - Due: -

Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02292654 Org: User:
Start: 05/01/15 End: 12/09/19 Due: 12/09/20

A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01452542 Org: User:
Start: 10/31/11 End: 11/30/11 Due: 11/30/12

Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen

Phase: N/A Priority: Normal
NCT ID: NCT04676373 Org: User:
Start: 03/10/21 End: 07/25/24 Due: 07/25/25

A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT

Phase: N/A Priority: Normal
NCT ID: NCT03368664 Org: User:
Start: 10/24/17 End: 12/31/25 Due: 12/31/26

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00005645 Org: User:
Start: 05/31/99 End: - Due: -

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00833768 Org: User:
Start: 01/31/09 End: 09/30/09 Due: 09/30/10

Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®

Phase: N/A Priority: Normal
NCT ID: NCT00731081 Org: User:
Start: 03/31/07 End: 05/31/09 Due: 05/31/10

A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients

Phase: N/A Priority: Normal
NCT ID: NCT00358150 Org: User:
Start: 06/30/06 End: 12/31/15 Due: 12/31/16

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Phase: N/A Priority: Normal
NCT ID: NCT00235300 Org: User:
Start: 05/31/00 End: 06/30/05 Due: 06/30/06

A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.

Phase: N/A Priority: Normal
NCT ID: NCT00312767 Org: User:
Start: 04/30/06 End: - Due: -

Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00047788 Org: User:
Start: 10/31/02 End: 05/31/04 Due: 05/31/05

Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02389452 Org: User:
Start: 02/28/10 End: 09/30/11 Due: 09/30/12

A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa

Phase: N/A Priority: Normal
NCT ID: NCT03019406 Org: User:
Start: 10/12/17 End: 12/30/26 Due: 12/30/27

A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00131768 Org: User:
Start: 11/30/03 End: 02/28/06 Due: 02/28/07

China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

Phase: N/A Priority: Normal
NCT ID: NCT06666413 Org: User:
Start: 05/07/25 End: 05/02/28 Due: 05/02/29

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT01597596 Org: User:
Start: 08/31/12 End: 12/31/14 Due: 12/31/15

Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

Phase: N/A Priority: Normal
NCT ID: NCT00763932 Org: User:
Start: 04/30/03 End: 07/31/06 Due: 07/31/07

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02222948 Org: User:
Start: 09/30/14 End: 07/31/16 Due: 07/31/17

Mucopolysaccharidosis I (MPS I) Registry

Phase: N/A Priority: Normal
NCT ID: NCT00144794 Org: User:
Start: 11/20/03 End: 01/31/34 Due: 01/31/35

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT00244257 Org: User:
Start: 08/31/05 End: 07/31/08 Due: 07/31/09

Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00140608 Org: User:
Start: 06/30/03 End: 05/31/05 Due: 05/31/06

Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT00069862 Org: User:
Start: 09/30/03 End: 11/30/05 Due: 11/30/06